Agenda
Friday, March 22, 2024
10:00-12:00 Vendor Setup
11:00-12:00 Attendee Check-in (Columbia Ballroom)
Badge and tram ticket provided at check-in
12:00-1:00 Lunch/Product Theater Presentation by Sanofi
New Era, New Data: The Evolving Story of Kevzara (sarilumab)
Orrin Troum, MD
1:00-1:15 Breaks/Exhibits
1:15-2:15 Session 1: Rheumatology Clinical Pearls
Angus Worthing, MD
2:15-2:30 Break/Exhibits
2:30-3:30 Session 2: Innovations in Rheumatology
Alvin Wells, MD
3:30-4:40 Product Theater Presentation by Alexion Rare Disease
Get Straight to the source of Hypophosphatasia (HPP)
Alvin Wells, MD
5:30-8:30 Opening Remarks and Welcome Dinner at Seven Glaciers
Saturday, March 23, 2024
8:00-9:00 Breakfast/Product Theater Presentation by Novartis
COSENTYX®(secukinumab) Cases: An Interactive Game-Based Challenge About Psoriatic Arthritis, Ankylosing Spondylitis, and Enthesitis-Related Arthritis
Stan Read, Associate Director, Thought Leader Liaison
9:00-10:00 Session 3: Rheumatology Advocacy Update for Alaska
Angus Worthing, MD
10:00-10:30 Break/Exhibits
10:30-11:30 Session 4: PsA Update
Arthur Kavanaugh, MD
11:30-12:00 Break/Exhibits/Hotel Checkout
12:00-1:00 Lunch/Product Theater Presentation by AbbVie
TNFI Nonresponders An Engaging Discussion on Efficacy and Safety in the Treatment of RA
Sanjay Chabra, DO
1:00-2:00 Session 5: Use of Clinical Measures to Treat RA
Martin Bergman, MD
2:00-2:30 Break/Exhibits
2:30-3:30 Session 6: Pediatric Rheumatology for the Adult Rheumatologist
Kabita Nanda, MD
3:30-4:00 Break/Exhibits
4:00-5:00 Session 7: Emerging Therapeutics in Systemic Lupus Erythematosus (SLE)
Yael "Ellie" Klionsky, MD
5:30-7:00 Closeout Reception for Learning Attendees** - Sponsored by Sanofi
**In Columbia Ballroom Foyer
Sunday, March 24, 2024
8:00-9:00 Breakfast/Product Theater Presentation by AstraZeneca
SAPHNELO® (anifrolumab-fnia): A First-In-Class IFN-1 Signaling Inhibitor, Now With 4-Year Data From a Long-Term Safety and Tolerability Study
Leanna Wise, MD
9:00-10:00 Session 8: Update on JAK inhibitors for Rheumatoid Arthritis
Orrin Troum, MD
10:00-10:30 Closing Comments